» Articles » PMID: 31663960

Substance Use Disorder Education in Medical Schools: A Scoping Review

Overview
Journal Acad Med
Specialty Medical Education
Date 2019 Oct 31
PMID 31663960
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: As medical schools adapt their curricula to prepare future physicians for the opioid crisis and for treating patients with substance use disorders (SUDs), educators should refer to courses described in the literature. This scoping review aimed to (1) provide a comprehensive evaluation and summation of peer-reviewed literature reporting on SUD education in medical schools globally and (2) appraise the research quality and educational outcomes reported in SUD education studies in medical schools.

Method: The authors searched 6 databases (3 Ovid MEDLINE databases, Embase, ERIC, and Web of Science) from inception through May 25, 2018. Original English-language research studies focusing on medical students and describing SUD education in medical schools were included. The Medical Education Research Study Quality Instrument (MERSQI) was used to assess included studies.

Results: Of 3,178 articles identified, 43 met inclusion criteria. Studies were conducted in 9 countries. Most reported on educational interventions for tobacco (n = 20; 47%); others reported on interventions for SUDs broadly (n = 15; 35%), alcohol (n = 8; 19%), and opioids (n = 1; 2%). The mean MERSQI score was 12.27 (standard deviation 2.30). Four studies (9%) reported on educational outcomes at the level of behaviors or patient or health care outcomes. The majority (n = 39; 91%) reported significant benefits.

Conclusions: Educational interventions relating to SUDs were effective in improving medical students' knowledge, skills, and attitudes. Educators should develop courses that achieve higher-level educational outcomes, increase education on opioid use disorders, and focus on the greatest public health concerns.

Citing Articles

Physician Interactions Associated With Increased Reception of Substance Use Disorder Treatment.

Smurzynski A, Gardere J, Ogunsakin O Cureus. 2025; 17(1):e76950.

PMID: 39906455 PMC: 11793833. DOI: 10.7759/cureus.76950.


Effects of Stigmatizing Language on Trainees' Clinical Decision-Making in Substance Use Disorders: A Randomized Controlled Trial.

Sheth N, Wilson A, West J, Schilling D, Rhee S, Napier T Acad Psychiatry. 2024; .

PMID: 39707107 DOI: 10.1007/s40596-024-02103-5.


Improving Medical Student Knowledge and Reducing Stigmatizing Attitudes Toward Treating Patients With Opioid Use Disorder.

Chung D, Slat S, Rao A, Thomas J, Kehne A, Macleod C Subst Use. 2024; 18:11782218241234808.

PMID: 38433746 PMC: 10908233. DOI: 10.1177/11782218241234808.


Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals.

Franz B, Dhanani L, Hall O, Brook D, Fenstemaker C, Simon J Addict Sci Clin Pract. 2024; 19(1):7.

PMID: 38243307 PMC: 10797921. DOI: 10.1186/s13722-024-00436-y.


Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US.

Franz B, Dhanani L, Hall O, Brook D, Simon J, Miller W Harm Reduct J. 2023; 20(1):180.

PMID: 38129903 PMC: 10740221. DOI: 10.1186/s12954-023-00918-3.